Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Alzheimer's Disease

Free Subscription 05.10.2026 8 Alzheimers Dement 1 BMC Geriatr 1 Brain 1 Brain Res 3 Curr Alzheimer Res 2 Exp Neurol 24 J Alzheimers Dis 1 J Neurochem 1 J Neurol 1 Nat Neurosci 1 Neurobiol Aging 1 Neurochem Res 1 Neurol Clin Pract 1 Neurol Genet 1 Neurology 1 Neuroscience 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Alzheimers Dement

1. BIZZI I, Macedo AC, Trudel L, Therriault J, et al
   Tau-PET correlates of mild behavioral impairment in preclinical and prodromal Alzheimer's disease: A head-to-head comparison of Flortaucipir and MK6240.
   Alzheimers Dement. 2026;22:e71861.
   PubMed         Abstract available
   
   
2. MOSTAFAEI S, Gustavsson K, Hagelin H, Mak JKL, et al
   Integrative prediction of Alzheimer's disease and related dementias using multi-omics aging clocks and genetic data.
   Alzheimers Dement. 2026;22:e71869.
   PubMed         Abstract available
   
   
3. GROWDON JH, Morris JC, Petersen RC, Sano M, et al
   Perspectives from Alzheimer's Disease Research Centers site directors on the early steps and the lasting impact.
   Alzheimers Dement. 2026;22:e71694.
   PubMed         Abstract available
   
   
4. HUANG S, Zhang Z, Xia J, Deng M, et al
   ZBP1-mediated Treg cell dysfunction exacerbates neuroimmune dysregulation in Alzheimer's disease under metabolic stress.
   Alzheimers Dement. 2026;22:e71896.
   PubMed         Abstract available
   
   
5. POPP Z, James A, Chivardi M, Reimer CJ, et al
   Practical considerations for characterization of the external exposome in Alzheimer's disease and related dementias cohorts.
   Alzheimers Dement. 2026;22:e71841.
   PubMed         Abstract available
   
   
6. ASHRAFZADEH-KIAN S, Figdore DJ, Bornhorst JA, Vanderboom PM, et al
   Long term clinical performance and analytical robustness of the Lumipulse plasma p-tau217 assay in routine clinical practice.
   Alzheimers Dement. 2026;22:e71887.
   PubMed         Abstract available
   
   
7. LI C, Zhao C, Lan Y, Ellis RJ, et al
   Exposome-wide association study and predictive risk score for incident Alzheimer's disease and related dementias.
   Alzheimers Dement. 2026;22:e71842.
   PubMed         Abstract available
   
   
8. ZHANG S, Roemer-Cassiano SN, Chong JR, Fang T, et al
   Excitation-inhibition imbalance links amyloid pathophysiology to cognition in non-demented individuals.
   Alzheimers Dement. 2026;22:e71891.
   PubMed         Abstract available
   
   

   
   BMC Geriatr

9. KAVLAK Y, Yildiz S, Yildiz P, Kar F, et al
   Effects of an eight-week combined exercise program on functional and sarcopenia-related outcomes in institutionalized older adults with and without Alzheimer's disease: a comparative intervention study.
   BMC Geriatr. 2026;26:1240.
   PubMed         Abstract available
   
   

   
   Brain

10. KOCH G, Martorana A, Santarnecchi E
    From network observation to network intervention in Alzheimer's disease.
    Brain. 2026 Sep 28:awag329. doi: 10.1093.
    PubMed        
    
    

    
    Brain Res

11. XUAN Z, Rahman MU, Ilyas M, Alioui Y, et al
    Gut bacterial isolates from individuals with Alzheimer's disease induce strain-specific intestinal, inflammatory, and neurobehavioral phenotypes in mice.
    Brain Res. 2026 Oct 1:150569. doi: 10.1016/j.brainres.2026.150569.
    PubMed         Abstract available
    
    

    
    Curr Alzheimer Res

12. JAMHOUR RMAQ, Salman HA, Alshammari M, Almuqati AF, et al
    Alzheimer's Disease: Silent Erosion of Memory - From Discovery to Modern Crisis and the Quest for a Cure.
    Curr Alzheimer Res. 2026 May 6. doi: 10.2174/0115672050423446251215051844.
    PubMed         Abstract available
    
    
13. PLUTA R, Bogucka-Kocka A, Kocki J, Bogucki J, et al
    Tau Protein, alpha-synuclein, and Amyloid Precursor Protein Processing Genes in the Frontal Cortex of an Ischemic Alzheimer's Disease Model.
    Curr Alzheimer Res. 2026 Mar 17:e15672050403689.
    PubMed         Abstract available
    
    
14. TIAN W, Hao Y, Qiu S, Chen Z, et al
    Genetic Evidence of Association Between Plasma Cathepsin L2 and Alzheimer's Disease: A Mendelian Randomization Study.
    Curr Alzheimer Res. 2026 Sep 29. doi: 10.2174/0115672050504771260920194040.
    PubMed         Abstract available
    
    

    
    Exp Neurol

15. SALEKI S, Wabant C, Loriot A, Stanga S, et al
    Alzheimer's disease-associated presenilin 2 N141I mutation impairs neuronal lipid homeostasis and mitochondrial dynamics through selective downregulation of the Golgi exchange factor Gbf1.
    Exp Neurol. 2026 Oct 1:116045. doi: 10.1016/j.expneurol.2026.116045.
    PubMed         Abstract available
    
    
16. YAGIHARA H, Saito Y, Takeuchi T, Seki K, et al
    Fluid amyloid-beta (Abeta) biomarkers reflect early beta-sheet-rich Abeta deposition during the preclinical stage in Alzheimer's disease model 5XFAD mice.
    Exp Neurol. 2026 Oct 1:116044. doi: 10.1016/j.expneurol.2026.116044.
    PubMed         Abstract available
    
    

    
    J Alzheimers Dis

17. VINTERS HV, Magaki S
    Amyloid-related imaging abnormalities after immunotherapy: How might brain microvascular basement membrane components be involved?
    J Alzheimers Dis. 2026;113:1052-1053.
    PubMed         Abstract available
    
    
18. AMEMIYA S, Takao H, Matsumoto S, Umeda-Kameyama Y, et al
    Subthreshold early white-matter hyperintensity increase predicts accelerated hippocampal and whole-brain atrophy in anti-amyloid-beta immunotherapy.
    J Alzheimers Dis. 2026;113:1099-1109.
    PubMed         Abstract available
    
    
19. AKSOY GUNDOGDU A, Samanci B, Alaylioglu M, Sahin E, et al
    Prognostic significance of cerebrospinal fluid tau biomarkers in amyloid-negative A-T + N + neurodegeneration: A retrospective cohort study.
    J Alzheimers Dis. 2026;113:1220-1231.
    PubMed         Abstract available
    
    
20. KANDILAKIS CL, Skondra M, Papageorgiou G, Konidari E, et al
    Comparison of Clock Drawing Test and Rey Complex Figure Test scoring methods for detecting mild and major neurocognitive disorder due to Alzheimer's disease in a real-world clinical setting.
    J Alzheimers Dis. 2026 Sep 28:13872877261490548. doi: 10.1177/13872877261490548.
    PubMed         Abstract available
    
    
21. MOTOLESE F, Ursini F, Norata D, Capone F, et al
    Estimating anti-amyloid therapy eligibility in Alzheimer's disease: A real-world retrospective study from an Italian memory clinic.
    J Alzheimers Dis. 2026 Sep 28:13872877261488813. doi: 10.1177/13872877261488813.
    PubMed         Abstract available
    
    
22. CAMPEDELLI L, Cicoli A, Lastretti M, Spagna S, et al
    Lithium exposure and risk of dementia and Alzheimer's disease: A systematic review and meta-analysis.
    J Alzheimers Dis. 2026 Sep 28:13872877261488808. doi: 10.1177/13872877261488808.
    PubMed         Abstract available
    
    
23. IPPATI S, Torelli F, Zamboni G, Iavarone A, et al
    Diagnosis and management of mild cognitive impairment and mild Alzheimer's disease dementia: Findings from an Italian real-world survey.
    J Alzheimers Dis. 2026 Sep 28:13872877261490595. doi: 10.1177/13872877261490595.
    PubMed         Abstract available
    
    
24. LOBO RR, Santos LTR, Peixoto Junior AA, Macedo DS, et al
    Alzheimer's disease polygenic risk scores and postoperative delirium: A promising marker, but not yet a clinical tool.
    J Alzheimers Dis. 2026 Sep 28:13872877261491985. doi: 10.1177/13872877261491985.
    PubMed         Abstract available
    
    
25. BRUUN M, Rune Nielsen T, Waldemar G, Frederiksen KS, et al
    Older adults' attitudes toward knowing their risk of Alzheimer's disease and preclinical diagnostic communication: A nationwide study.
    J Alzheimers Dis. 2026 Sep 28:13872877261489585. doi: 10.1177/13872877261489585.
    PubMed         Abstract available
    
    
26. WANG X, Huang Y, Li J
    Integrating transcriptomic data to identify calmodulin-related diagnostic biomarkers for Alzheimer's disease.
    J Alzheimers Dis. 2026 Sep 28:13872877261487604. doi: 10.1177/13872877261487604.
    PubMed         Abstract available
    
    
27. ALI M, Shabbir H, Shaharyar M, Mukesh S, et al
    Efficacy and safety of aducanumab, lecanemab, and donanemab in Alzheimer's disease: A meta-analysis of randomized controlled trials.
    J Alzheimers Dis. 2026 Sep 28:13872877261488812. doi: 10.1177/13872877261488812.
    PubMed         Abstract available
    
    
28. XU MY, Bai YD, Zeng XQ, Tan CR, et al
    Bazedoxifene restores myelin changes and attenuates cognitive deficits in a mouse model of Alzheimer's disease.
    J Alzheimers Dis. 2026 Oct 1:13872877261490479. doi: 10.1177/13872877261490479.
    PubMed         Abstract available
    
    
29. XIAO H, Wang J, Wan S
    WIMOAD: Weighted Integration of Multi-Omics data with meta learning for Alzheimer's Disease diagnosis.
    J Alzheimers Dis. 2026 Sep 30:13872877261491975. doi: 10.1177/13872877261491975.
    PubMed         Abstract available
    
    
30. LOPES-GOMES E, Resende FFB, Greuel AM, Marina CL, et al
    Clinical and neuropathological aspects of canine cognitive dysfunction syndrome and a translational perspective for Alzheimer's disease.
    J Alzheimers Dis. 2026 Sep 30:13872877261491819. doi: 10.1177/13872877261491819.
    PubMed         Abstract available
    
    
31. NING X, Xiao Y, Wang N, Jiao X, et al
    The efficacy of donepezil combination therapy strategies in Alzheimer's disease: A systematic review and network meta-analysis.
    J Alzheimers Dis. 2026 Sep 30:13872877261491977. doi: 10.1177/13872877261491977.
    PubMed         Abstract available
    
    
32. PINTUS M, Valletta M, Sacchi L, Carandini T, et al
    Exploring the interplay between frailty, Alzheimer's disease biomarkers, and cognitive functioning in patients with mild cognitive impairment: A cross-sectional study.
    J Alzheimers Dis. 2026 Sep 30:13872877261487377. doi: 10.1177/13872877261487377.
    PubMed         Abstract available
    
    
33. GONCALO AK
    The role of neuroinflammation in the connections between autism spectrum disorder and Alzheimer's disease and related dementias: A review.
    J Alzheimers Dis. 2026 Sep 30:13872877261491809. doi: 10.1177/13872877261491809.
    PubMed         Abstract available
    
    
34. AABY P, Arnold SE, Benn CS, Ben-Haim S, et al
    Immune boosting to combat Alzheimer's disease: Position statement.
    J Alzheimers Dis. 2026 Sep 29:13872877261472830. doi: 10.1177/13872877261472830.
    PubMed         Abstract available
    
    
35. LIN X, Honardoost MA, Ahern S, Taylor C, et al
    Rural-urban disparities in the clinical diagnostic pathway of patients with all-cause mild cognitive impairment and dementia due to Alzheimer's disease in Australia.
    J Alzheimers Dis. 2026 Sep 29:13872877261489828. doi: 10.1177/13872877261489828.
    PubMed         Abstract available
    
    
36. PARK BY, Jo SW, Park TY, Kim H, et al
    Feasibility and safety of repeated low-intensity ultrasound in amyloid PET-positive early Alzheimer's disease: A prospective pilot study.
    J Alzheimers Dis. 2026 Sep 29:13872877261493067. doi: 10.1177/13872877261493067.
    PubMed         Abstract available
    
    
37. HONG Y, Shen N, Yang H, Ahmed G, et al
    The role of acupuncture in the dendritic cell vaccine against Alzheimer's disease.
    J Alzheimers Dis. 2026 Sep 29:13872877261490135. doi: 10.1177/13872877261490135.
    PubMed         Abstract available
    
    
38. YU H, Chang W, Mahmut D, Huang C, et al
    Integrative transcriptomic and regulatory network analysis reveals associations of seven proposed risk genes with immune-related molecular features in Alzheimer's disease.
    J Alzheimers Dis. 2026 Sep 30:13872877261493169. doi: 10.1177/13872877261493169.
    PubMed         Abstract available
    
    
39. MAR J, Arrospide A, Handels R, Soto-Gordoa M, et al
    Economic model of Alzheimer's disease that incorporates the uncertainty associated with measuring efficacy in clinical trials.
    J Alzheimers Dis. 2026 Sep 30:13872877261490543. doi: 10.1177/13872877261490543.
    PubMed         Abstract available
    
    
40. LI B, Shi T, Yang M, Liu H, et al
    Nonlinear association between waist-to-height ratio and Alzheimer's disease among middle-aged and older adults: A cross-sectional study from NHANES.
    J Alzheimers Dis. 2026 Sep 30:13872877261490818. doi: 10.1177/13872877261490818.
    PubMed         Abstract available
    
    

    
    J Neurochem

41. NICOL NI, Li T, Su Q, Suhocki A, et al
    AMPK Activator MK-8722 Improves Spatial Memory Deficit and Alters Metabolome in APP/PS1 AD Mouse Model.
    J Neurochem. 2026;170:e70563.
    PubMed         Abstract available
    
    

    
    J Neurol

42. BAUN AM, Iranzo A, Terkelsen MH, Hinz R, et al
    Multimodal PET-MRI profiling predicts dementia with Lewy bodies in isolated REM sleep behaviour disorder.
    J Neurol. 2026;273:635.
    PubMed         Abstract available
    
    

    
    Nat Neurosci

43. RITTMO J, Franzmeier N, Strandberg O, Chauveau L, et al
    Different functional connectivity gradients reflect aging and Alzheimer's disease.
    Nat Neurosci. 2026 Oct 1. doi: 10.1038/s41593-026-02402.
    PubMed         Abstract available
    
    

    
    Neurobiol Aging

44. GARCIA D, Saito N, Tamizharasu S, Sevilla LNC, et al
    Regional distribution of mineralized blood vessels in Alzheimer disease and clinicopathological associations: A multicenter autopsy study.
    Neurobiol Aging. 2026;169:141-152.
    PubMed         Abstract available
    
    

    
    Neurochem Res

45. ZHU S, Liu M, Chen J, Zhou L, et al
    Long Non-Coding RNA PART1 in Alzheimer's Disease: Clinical Value and Improvement of Neurotoxicity and Apoptosis via miR-770-5p.
    Neurochem Res. 2026;51:278.
    PubMed         Abstract available
    
    

    
    Neurol Clin Pract

46. ZAFAR SF, Moura LMVR, Gorham B, Ndemo E, et al
    Geographic Variation in Diagnostic Codes Associated With Mild Cognitive Impairment, Alzheimer Disease, and Related Dementias.
    Neurol Clin Pract. 2026;16:e200658.
    PubMed         Abstract available
    
    

    
    Neurol Genet

47. CARO-CHATELIER I, Sargurupremraj M, Yang C, Akinleye C, et al
    Genetic Insights Into Protective Effects of GLP-1 Receptor Agonists on Stroke and Alzheimer Disease Across Ancestries.
    Neurol Genet. 2026;12:e200425.
    PubMed         Abstract available
    
    

    
    Neurology

48. SHIR D, Algeciras-Schimnich A, Piura YD, Bornhorst JA, et al
    Clinical Factors Associated With Discordant Plasma P-Tau217 and Established Alzheimer Disease Biomarkers.
    Neurology. 2026;107:e218591.
    PubMed         Abstract available
    
    

    
    Neuroscience

49. ALRESHIDI NF, Al-Qahtani SA, Almasoudi KS, Mirza IM, et al
    Lower serum serotonin is associated with greater cardiovascular risk burden and poorer cognitive outcomes in mild cognitive impairment and amyloid-positive participants.
    Neuroscience. 2026;615:334-350.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

50. AUGUR ZM, Fogo GM, Benoit CR, Kearney MA, et al
    BAG3 coordinates astrocytic proteostasis of Alzheimer's disease-linked proteins via proteasome, autophagy, and retromer interactions.
    Proc Natl Acad Sci U S A. 2026;123:e2528514123.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum